Security record · archived quarter
AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
11Tracked holders
0Δ holders
2.55MShares held
$61.16MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -1.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | — | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | — | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | — | — |
| Q2 2024 | 11 | — | 2.57M | $51.15M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.05M | +1.6% | $25.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.05M | +1.6% | $25.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Arrowstreet Capital ✦ | 454.93K | +368.1% | $10.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 345.73K | -28.9% | $8.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 174.24K | -30.1% | $4.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 139.30K | -5.2% | $3.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 139.30K | -5.2% | $3.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 139.30K | -5.2% | $3.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 114.98K | -6.3% | $2.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 98.93K | -54.5% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 98.93K | -54.5% | $2.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 65.22K | +0.9% | $1.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 60.28K | -41.8% | $1.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 26.81K | -2.6% | $644,220 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 10.47K | -35.1% | $251,618 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 44.71M shares, $512.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API